NEW YORK (GenomeWeb) – Adoptees signing up for direct-to-consumer genomic testing services often hope to fill the gaps in their family health history and genetic disease risk profile, but they do not differ from nonadoptees in the way they use the results to improve their health, according to a new study by researchers at Brigham and Women's Hospital and Harvard Medical School.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.